Clinical products

Tender description

Double blind randomised clinical IMP trial: manufacture of liquid form of 2 active ingredients and matching placebo, provision of dossier for MHRA application and approval, labelling, storage and distribution of the IMP and placebo as required. Tender for the manufacturing, packaging, labelling, shipping and storage of x2 Investigational Medical Product’s (IMP) and placebo and associated project management. This contract covers the period from execution of contract (estimated to be August 2018) to supply of final IMPs to last patient (estimated to be September 2020). There will be an option to extend for a further year.